Uwell Biopharma, Inc. (TPEX:7902)
46.00
-3.95 (-7.91%)
At close: Feb 26, 2026
489.74% (1Y)
| Market Cap | 9.20B |
| Revenue (ttm) | 450.00K |
| Net Income (ttm) | -54.86M |
| Shares Out | 200.00M |
| EPS (ttm) | -0.47 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,843,206 |
| Average Volume | 1,406,019 |
| Open | 49.95 |
| Previous Close | 49.95 |
| Day's Range | 44.90 - 49.95 |
| 52-Week Range | 7.80 - 51.50 |
| Beta | n/a |
| RSI | 70.50 |
| Earnings Date | n/a |